Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00795951 · ClinicalTrials.gov registry record · Phase 4
Clinical Evaluation of T.R.U.E. TEST in Children and Adolescents
A Phase 4 study, sponsored by Allerderm.
- Completed
- Registry status
- Phase 4
- Development phase
- 102
- Enrollment target
NCT00795951 is a Phase 4 study that has completed, run by Allerderm. The registered enrollment target is 102 participants.
The verdict
NCT00795951, a Phase 4 study, has completed, sponsored by Allerderm.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 102 participants
- Enrollment target
Study Summary
Open, prospective, single-site, non-randomized study of the efficacy and safety of T.R.U.E. TEST allergens in children and adolescents ages 6-18.
Interventions
- BIOLOGICAL T.R.U.E. Test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 102 participants |
| Start Date | 2008-11 |
| Est. Completion | 2009-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00795951
The ClinicalTrials.gov registry entry for NCT00795951 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 102 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Allerderm, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which T.R.U.E. Test is the first listed.
NCT00795951 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00795951 about?
NCT00795951 is a clinical study titled "Clinical Evaluation of T.R.U.E. TEST in Children and Adolescents". Open, prospective, single-site, non-randomized study of the efficacy and safety of T.R.U.E. TEST allergens in children and adolescents ages 6-18.
What is the current status of trial NCT00795951?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 102 participants. The study started on 2008-11. Estimated completion is 2009-11.
What interventions are being tested in trial NCT00795951?
The interventions under investigation include: T.R.U.E. Test (BIOLOGICAL).
Who is sponsoring clinical trial NCT00795951?
This trial is sponsored by Allerderm, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.